S&P 500 7,575 +1.23% Nasdaq 26,282 +1.74% Dow Jones 52,637 -0.50% FTSE 100 10,497 -1.70% DAX 25,067 -2.76% Nikkei 225 68,558 -1.69% Hang Seng 24,175 +3.53% WTI Crude 71.41 +1.38% Gold 4,114 -0.76% US 10-Year Treasury Yield 4.569 +2.01% S&P 500 7,575 +1.23% Nasdaq 26,282 +1.74% Dow Jones 52,637 -0.50% FTSE 100 10,497 -1.70% DAX 25,067 -2.76% Nikkei 225 68,558 -1.69% Hang Seng 24,175 +3.53% WTI Crude 71.41 +1.38% Gold 4,114 -0.76% US 10-Year Treasury Yield 4.569 +2.01%

LATEST

Inflows to multi-asset allocation funds jumps 22% MoM amid increased stock market volatility●Reddit may have a search edge social rivals lack●Big-Box Retailers Have a New Strategy for Breaking Into Urban Markets●Amazon discounted a foldable electric scooter to a rare $160 price●A Port Strike and a Tight Budget Squeeze Uruguay’s President●Suriname Draws a Fourth Offshore Oil Bid in Under a Month●Spain’s Dominion Makes Chile a Priority Market for Growth●Jamaica’s Regulator Probes an Insurance Clause Cutting Melissa Payouts●Inflows to multi-asset allocation funds jumps 22% MoM amid increased stock market volatility●Reddit may have a search edge social rivals lack●Big-Box Retailers Have a New Strategy for Breaking Into Urban Markets●Amazon discounted a foldable electric scooter to a rare $160 price●A Port Strike and a Tight Budget Squeeze Uruguay’s President●Suriname Draws a Fourth Offshore Oil Bid in Under a Month●Spain’s Dominion Makes Chile a Priority Market for Growth●Jamaica’s Regulator Probes an Insurance Clause Cutting Melissa Payouts●

Europe

AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse

Europe News · 2d ago

AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse

A late-stage clinical trial failed to miss its primary endpoint, U.K.'s laregst drugmaker said Thursday.

Read the full story at Europe News →

EUROS aggregates the world's financial press. The full article lives with the newsroom that reported it.

More Europe

Korean market expects unanimous BoK rate rise

bne IntelliNews · 12h ago

Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC

Europe News · 1d ago

EasyJet pops 13% as airline weighs $7.7 billion rival takeover bid from Apollo

Europe News · 2d ago

Volkswagen unveils four-year plan but lacks backing for overhaul with up to 100,000 job cuts

Business | Euronews RSS · 2d ago